Questions discussed in this category
How do we approach patients with rare tumors given the paucity of data?
Would you consider stopping therapy versus doxorubicin + dacarbazine/doxorubicin alone versus alternative chemotherapy ?
Patient initially achieved CR with VAC-IE with resolution of presumed lung mets and 100% necrosis in LLE primary tumor on BKA. Then was NED again afte...
J Clin Oncol 40, 2022 (suppl 17; abstr LBA2). https://meetings.asco.org/abstracts-presentations/209024
Ewing sarcoma of the right lung, status post bi-lobectomy and adjuvant VDC/IE, with recurrence 6 years in the right lung only. He has reached a cumula...
This is particularly relevant for patients with extensive delays due to wound healing issues.
Does the degree of resectability affect your management?
Individuals often cite ARST0332 to justify radiation omission in high grade R0 resections, but R0 was defined as > 5 mm margins.
If a staging RPLND is NOT performed, is there a role for prophylactically irradiating the lymph nodes, even in the setting of a negative PET/CT at dia...
How do you incorporate PD-L1 blockade?
In particular, is there any data on the efficacy of Ipilimumab/Nivolumab?
Patient received Pazopanib upfront with Ifos/Dox. Pulmonary metastatectomy is not an option as there are multiple mets.
What if the patient had also received HIPEC prior?
If you do what dose and fractionation do you recommend?
Presented with mass projecting into right/left anterior ethmoid complex
The patient previously received the P6 regimen.
Should treatment be based on current histology (rhabdomyosarcoma) or origin (germ cell)?
Is there a role for adjuvant radiation? Other chemotherapy options?
Is there a role for immunotherapy outside of trial setting?
Is there any role for consolidative RT/CRT to the lung and mediastinum after initial chemo? What dose and fractionation would be most appropriate for ...
Can you use SBRT for boost?
What is the risk of joint issues if you treat the epitrochlear nodes?
1891691011876618867173851436516016149941613315355153331310613687122608807111299001036090498710100849225867179347436753271166930393337641903957958
Papers discussed in this category
Clin. Cancer Res.,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003-04-15
Cancer, 2011-06-15
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015-09-20
The Lancet. Oncology, 2016-10
Sarcoma, 2014
Int. J. Radiat. Oncol. Biol. Phys., 2018 Aug 02
International journal of radiation oncology, biology, physics, 2012-05-01
Cancer, 2017-06-15
Eur J Cancer, 2020 Dec 07
Cancer, 2014-04-01
The Lancet. Oncology, 2018-03
The Lancet. Oncology, 2019-06
J Hematol Oncol, 2016 Jun 03
The Lancet. Oncology, 2017-11
International journal of radiation oncology, biology, physics, 2012-02-01
JAMA Oncol, 2020 Feb 20
Pediatr Blood Cancer, 2016 Mar 22
Lung Cancer, 2016 Apr 26
Eur J Cancer, 2015 Feb 13
J Surg Oncol, 2020 Oct
Lancet Oncol, 2019 Nov 27
Radiother Oncol, 2016 May 17
Pediatr Blood Cancer, 2022 Oct 02
Clin Cancer Res, 2023 Jan 09
Pediatric blood & cancer, 2018-02
The American journal of cardiology, 2018-12-01
Curr Oncol, 2021 Oct 13
Cardiooncology, 2019 Jan 29
International journal of radiation oncology, biology, physics, 2005-11-15
J Adolesc Young Adult Oncol, 2019 Nov 08
Eur J Cancer, 2017 Nov 28
European journal of cancer (Oxford, England : 1990), 2007 Jan 30
JAMA oncology, 2018 Jan 01
Clin Cancer Res, 2021 Mar 25
Clinical cancer research : an official journal of the American Association for Cancer Research, 2021 Feb 25
Clinical cancer research : an official journal of the American Association for Cancer Research, 2021 May 14
European journal of cancer (Oxford, England : 1990), 2011 Jun 22
The Lancet. Oncology, 2014 Mar 05
European journal of cancer (Oxford, England : 1990), 2019 Jan 25